Acute Aortic Syndrome Clinical Trial
Official title:
Effects of Thymosin α1 on Inflammatory Response for Acute Aortic Syndrome Patients
Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are the major causes of death in patients with acute aortic syndrome (AAS). Therefore, the prevention of SIRS and MODS is of great clinical value, and immunomodulatory therapy with thymosin alpha 1 may be beneficial. This study was designed to test the hypothesis that the administration of thymosin alpha 1 during the acute phase of AAS will result in a reduced incidence of SIRS and MODS.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03647566 -
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
|
||
| Recruiting |
NCT05965453 -
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
|
||
| Recruiting |
NCT06277895 -
VOCs in Patients With Acute Cardiogenic Chest Pain
|
N/A | |
| Completed |
NCT02273245 -
Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?
|
N/A | |
| Recruiting |
NCT04699279 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I
|
N/A | |
| Completed |
NCT04711889 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II
|
N/A | |
| Enrolling by invitation |
NCT04398992 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
|
||
| Completed |
NCT04751058 -
Genetic Profile in Patients With Aortic Syndrome
|
||
| Completed |
NCT04430400 -
Integrated Diagnostic Algorithm for Acute Aortic Syndromes
|
||
| Completed |
NCT01259843 -
French National Observatory of Aortic Syndromes
|